About Anne

Anne Loarec, MD, MSc, is Medical Epidemiologist, Epicentre, Medecins Sans Frontières/Doctor without Borders, Paris, France.

Anne Loarec is a medical doctor. She completed her Master in  Epidemiology at the London School of Hygiene and Tropical Medicine in 2013. She has been working with Doctors without Borders (MSF) since 2004 and joined Epicentre, the MSF epidemiology satellite in 2013. Today, she is coordinating the HCV monitoring for MSF projects and several studies linked to diagnostic and care for Hepatitis infections. 

This speaker will be presenting at the following session(s)

  • Speeding access to innovative hepatitis C products: Unitaid’s key role

    Chagal

    Day: 1 November

    Time: 17:30

    This evening side meeting presents Unitaid’s investment and operating model in the context of the emerging global response to hepatitis C. It will share the results of Unitaid-funded projects related to hepatitis C. It will also explore opportunities for potential future investments. 

    Presentations:

    • Opening remarks – Unitaid’s model and its relevance for Hepatitis C.
    • Where are we today?
    • Developing a simplified mode of care for HCV.
      Anne Loarec, Médicins Sans Frontère
    • Creating demand and innovative solutions for access to HCV treatment.
      Khalil Elouardighi, Coalition Plus
    • Facilitating access to HCV treatment through voluntary licensing
      Greg Perry, Medicines Patent Pool
    • Facilitating diagnostic solutions
      Francesco Marinucci, FIND
    • Putting the pieces together to maximise benefits.
      Dr. Marc Bulterys, World Health Organization
    • Moderated discussion.